As the only open-irrigated RF catheter with industrial diamonds to optimize power based on tissue surface temperature, the DiamondTemp™ ablation system (DTA) with RealTemp™ is safe and effective, and has demonstrated procedural efficiencies compared to contact force-sensing RF.1Product Details
The Arctic Front family of cryoballoons are approved in the United States to treat drug refractory, recurrent, symptomatic, paroxysmal and persistent atrial fibrillation (episode duration less than 6 months). The catheters have a proven safety and efficacy profile in treating AF.2Product Details
The Achieve™ and Achieve Advance™ Mapping Catheters are intra-cardiac electrophysiology diagnostic catheters designed for use with the Arctic Front family of cardiac cryoablation catheters, the FlexCath™ Advance Steerable Sheath, and the CryoConsole™.Product Details
The Freezor™ family of cardiac cryoablation catheters are flexible, single-use, minimally invasive devices designed to ablate cardiac tissue. Used in conjunction with the CryoConsole, they are the only focal catheters that utilize the cryo energy source, with ablation indications ranging from atrioventricular nodal reentry tachycardia (AVNRT) to atrial arrhythmias.Product Details
The CryoConsole houses the components and software needed to perform cryoablation procedures with the Arctic Front family of cardiac cryoablation catheters or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.Product Details
The FlexCath Advance™ Steerable Sheath is part of the Arctic Front Cardiac Cryoablation Catheter System and is the only sheath that has been tested for use with the Arctic Front family of cardiac cryoablation catheters. It can also be used with the Freezor™ MAX Cardiac Cryoablation Catheter.Product Details
Kautzner J, Albenque JP, Natale A, et al. A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation. JACC Clin Electrophysiol. Published online January 27, 2021.
Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. April 23, 2013;61(16):1713-23.